Zoetis Inc. (ZTS)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ZTS is $98.57, 24.2% above the last close of $79.38 on Oct 16, 2026; targets range from $74.91 to $159.21. Rating consensus: Buy.
Snapshot
- P/E13.1x
- P/E vs sector-53.6%
- P/E vs own-32.0%
- Target upside+24.2%
- ConsensusBuy
- Market cap$32.78B
- FCF yield+7.2%
- InsidersNone in 90d
- Earnings in20d
- News
Why it moved
Zoetis Inc. (ZTS) rose 1.2% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.8%. Most of the move is specific to ZTS.
1 story on the day (30-day average 0.6).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $79.38 · -43.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▼
- Above MAs3 of 4 above
- MA20×50↑ in ~8d
- RSI69
- Support-2.0%
- Resistance+2.3%
- Off 52w high-45.2%
- Off ATH-66.0%
- 52w range$79.38
- Bollingerabove upper
- MACD1.00
- ATR+2.5%
- Volume1.3x
Analyst price targets
9 firms with a target in the last 12 months · last close $79.38 · as of Oct 16, 2026
Strong buy 4 · Buy 4 · Hold 10 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +0.3% year over year, free cash flow 21.8% of revenue, operating margin 38.0%.
| Q2 FY2026 | Jun 30, 2026 | $2.47B | 1.65 | $538M | 72.7% | 38.0% | 28.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.26B | 1.42 | $291M | 71.7% | 36.3% | 26.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.39B | 1.37 | $732M | 68.9% | 34.6% | 25.3% |
| Q3 FY2025 | Sep 30, 2025 | $2.4B | 1.63 | $805M | 70.2% | 39.0% | 30.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.46B | 1.61 | $308M | 72.3% | 40.2% | 29.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.22B | 1.41 | $438M | 70.5% | 38.1% | 28.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.32B | 1.29 | $689M | 68.0% | 33.0% | 25.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.39B | 1.50 | $784M | 69.2% | 38.5% | 28.6% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $232.65 | -1.1% | -1.1% | +2.7% | 41.2 | $34.37B | |
| 2 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B | |
| 3 |  | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 4 | | $79.38 | +1.2% | -45.2% | +24.2% | 13.1 | $32.78B | |
| 5 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 6 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 7 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 8 |  | $18.66 | +2.4% | 0.0% | +9.8% | — | $21.43B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.